WO1998017266A3 - Preparation pharmaceutique contenant un derive d'amidine et de la procaine - Google Patents

Preparation pharmaceutique contenant un derive d'amidine et de la procaine Download PDF

Info

Publication number
WO1998017266A3
WO1998017266A3 PCT/EP1997/005724 EP9705724W WO9817266A3 WO 1998017266 A3 WO1998017266 A3 WO 1998017266A3 EP 9705724 W EP9705724 W EP 9705724W WO 9817266 A3 WO9817266 A3 WO 9817266A3
Authority
WO
WIPO (PCT)
Prior art keywords
pharmaceutical preparation
trypanosomiasis
prevention
treatment
procaine
Prior art date
Application number
PCT/EP1997/005724
Other languages
German (de)
English (en)
Other versions
WO1998017266A2 (fr
Inventor
Alain Jacques Bourdichon
Original Assignee
Alain Jacques Bourdichon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alain Jacques Bourdichon filed Critical Alain Jacques Bourdichon
Priority to EP97912195A priority Critical patent/EP0936907A2/fr
Priority to AU49482/97A priority patent/AU4948297A/en
Publication of WO1998017266A2 publication Critical patent/WO1998017266A2/fr
Publication of WO1998017266A3 publication Critical patent/WO1998017266A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention vise à mettre au point une préparation pharmaceutique permettant d'assurer la prophylaxie de trypanosomiase. A cet effet, il est prévu une préparation pharmaceutique se caractérisant en ce qu'elle contient au moins un composé du groupe comprenant les amidines et la procaïne ou un dérivé de procaïne, ledit composé étant actif à l'encontre de protozoaires.
PCT/EP1997/005724 1996-10-18 1997-10-17 Preparation pharmaceutique contenant un derive d'amidine et de la procaine WO1998017266A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP97912195A EP0936907A2 (fr) 1996-10-18 1997-10-17 Preparation pharmaceutique contenant un derive d'amidine et de la procaine
AU49482/97A AU4948297A (en) 1996-10-18 1997-10-17 Pharmaceutical preparation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE29618094.7 1996-10-18
DE29618094U DE29618094U1 (de) 1996-10-18 1996-10-18 Pharmazeutisches Präparat

Publications (2)

Publication Number Publication Date
WO1998017266A2 WO1998017266A2 (fr) 1998-04-30
WO1998017266A3 true WO1998017266A3 (fr) 1998-06-25

Family

ID=8030722

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1997/005724 WO1998017266A2 (fr) 1996-10-18 1997-10-17 Preparation pharmaceutique contenant un derive d'amidine et de la procaine

Country Status (4)

Country Link
EP (1) EP0936907A2 (fr)
AU (1) AU4948297A (fr)
DE (1) DE29618094U1 (fr)
WO (1) WO1998017266A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19853937A1 (de) * 1998-11-24 2000-05-25 Chambord Ltd Pharmazeutisches Präparat

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4309415A1 (de) * 1993-03-19 1994-09-22 Alan Jacques Bourdichon Pharmazeutisches Präparat
EP0643964A2 (fr) * 1993-08-18 1995-03-22 Medipharma S.A. Utilisation d'anesthétiques locaux pour la fabrication d'un médicament pour protéger les membranes de cellules plasmatiques
WO1997006769A2 (fr) * 1995-08-21 1997-02-27 Bourdichon Alain Jacques Composition pharmaceutique a proprietes trypanocides

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4309415A1 (de) * 1993-03-19 1994-09-22 Alan Jacques Bourdichon Pharmazeutisches Präparat
EP0643964A2 (fr) * 1993-08-18 1995-03-22 Medipharma S.A. Utilisation d'anesthétiques locaux pour la fabrication d'un médicament pour protéger les membranes de cellules plasmatiques
WO1997006769A2 (fr) * 1995-08-21 1997-02-27 Bourdichon Alain Jacques Composition pharmaceutique a proprietes trypanocides

Also Published As

Publication number Publication date
DE29618094U1 (de) 1998-02-12
WO1998017266A2 (fr) 1998-04-30
EP0936907A2 (fr) 1999-08-25
AU4948297A (en) 1998-05-15

Similar Documents

Publication Publication Date Title
WO1996021655A3 (fr) Inhibiteurs de la calpaine et/ou de la cathepsine b derives d&#39;oxazolidine substituee
WO1998006742A3 (fr) Peptides servant a traiter des etats d&#39;inflammation et de choc
MY117032A (en) A novel compound form.
ZA200110504B (en) Dietary or pharmaceutical compositions for use for the prevention or treatment of hyperoxaluria.
CA2151883A1 (fr) Tropoelastine synthetique
IL125735A (en) Pharmaceutical compositions for the treatment of glaucoma comprising an inhibitor of serine-threonine kinase, tyrosine kinase or protein tyrosine phosphatase or an actin-disrupting compound
AU2001260400A1 (en) Use of hydrogenotrophic acetogenic strains for preventing or treating digestive disorders
EP0825867A4 (fr) N,o-carboxymethylchitosan pour la prevention des adhesions chirurgicales
EP0935963A3 (fr) Utilisation des inhibiteurs selectifs de MMP-13 pour le traitement de l&#39;osteoarthrite et autres maladies mediées par le matrix metalloproteinase
AU2001284690A1 (en) Compositions exhibiting synergistic inhibition of the expression and/or activityof cyclooxygenase-2
HK1027280A1 (en) Plant extracts for the treatment of increased boneresorption.
AU1440395A (en) Methods for the treatment or prevention of conditions associated with amyloidogenic reptides
BG102818A (en) D-manitol and method for its preparation
CA2199844A1 (fr) Composition pour le traitement d&#39;affections de la peau
HUP9903166A3 (en) Medicinal compositions for the prophylaxis or treatment of arteriosclerosis
WO1998036730A3 (fr) Compositions de traitement de l&#39;acne rosacee
AU4203297A (en) The use of proteinase inhibitors for prevention or reduction of bone resorption
AU6232794A (en) The use of nitric oxide-delivering compounds for the treatment or prevention of alcoholic liver injury
AU1067599A (en) Peptide compositions for the treatment and prevention of hiv infection
AU5636300A (en) Use of creatine or creatine analogs for the prevention and treatment of transmissible spongiform encephalopathies
EP1032556A4 (fr) Composes pharmaceutiquement actifs et procedes d&#39;utilisation
PL354413A1 (en) Composition for the prevention and/or treatment of circulatory disorders, comprising derivatives of l-carnitine and extracts ofginkgo biloba
AU3899893A (en) Compositions for the treatment of acute or chronic inflammation
ZA97252B (en) Compositions for the prevention and treatment of osteoporosis.
EP0676951A4 (fr) Utilisation de glycosides de vitamine d pour le traitement ou la prevention de l&#39;osteoporose.

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ

AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 1997912195

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1997912195

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: CA

WWW Wipo information: withdrawn in national office

Ref document number: 1997912195

Country of ref document: EP